| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/04/2013 | CN102552479B Chinese herbal medicine composition for treating diabetic foot |
| 12/04/2013 | CN102552163B Metoprolol tartrate sustained release pellet and preparation method thereof |
| 12/04/2013 | CN102526640B Pantoprazole sodium medicine compound and preparation technology thereof |
| 12/04/2013 | CN102526509B Medicine for treating hepatomegaly |
| 12/04/2013 | CN102503803B Organic acid compound as well as extraction method and application thereof |
| 12/04/2013 | CN102462738B Traditional Chinese medicine composition having effects of reducing blood sugar and resisting oxidation, and preparation method thereof |
| 12/04/2013 | CN102462672B Ramosetron transdermal patch and preparation method thereof |
| 12/04/2013 | CN102462669B Troxipide dispersible tablet and preparation method thereof |
| 12/04/2013 | CN102432620B Resveratrol tetramer compound, its preparation method and application |
| 12/04/2013 | CN102427807B Anti-obesity agent comprising compound containing benzotropolone ring |
| 12/04/2013 | CN102423357B Compound propolis composition spray for treating livestock foot-and-mouth disease and its preparation method |
| 12/04/2013 | CN102397330B Compound oil-in-water schizonepeta spike oil nanoemulsion composition and preparation method thereof |
| 12/04/2013 | CN102320947B Polyphenol compound contained in tobacco, preparation method and application thereof |
| 12/04/2013 | CN102304086B Heterocyclic inhibitors of MEK and methods of use thereof |
| 12/04/2013 | CN102300865B Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases |
| 12/04/2013 | CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones |
| 12/04/2013 | CN102292081B Pharmaceutical association lipoic acid and hydroxycitric acid as active ingredients |
| 12/04/2013 | CN102274265B Compound propolis composition for treating livestock mastitis and preparation method thereof |
| 12/04/2013 | CN102268020B Ceftiofur acetoxy ethyl ester and preparation method thereof |
| 12/04/2013 | CN102170876B Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 12/04/2013 | CN102159586B C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 12/04/2013 | CN102149400B Compositions that aim to promote the development and growth of a beneficial vaginal microflora |
| 12/04/2013 | CN102127114B Non-natural chiral amino acid derivative with di-organic phosphate group and synthesis method thereof |
| 12/04/2013 | CN102119142B Salicylamide derivatives as nicotinic alpha 7 modulators |
| 12/04/2013 | CN102115472B 3-(2-pyrromethene)azaindoline-2-one derivatives and preparation method and application thereof |
| 12/04/2013 | CN102066343B Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 12/04/2013 | CN102058642B Ginseng saponin extract and preparation method thereof |
| 12/04/2013 | CN102038950B Novel immune adjuvant and vaccine containing same |
| 12/04/2013 | CN102001921B Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof |
| 12/04/2013 | CN101925603B Modulators of cystic fibrosis transmembrane conductance regulator |
| 12/04/2013 | CN101925348B Biodegradable single-phase cohesive hydrogel |
| 12/04/2013 | CN101910156B Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 12/04/2013 | CN101909610B Composition for oral administration |
| 12/04/2013 | CN101889987B Method for preparing novel cefixime tablets and cefixime capsules |
| 12/04/2013 | CN101869616B Hair nourishing liquid and manufacturing method thereof |
| 12/04/2013 | CN101862326B Medicine compound containing febuxostat |
| 12/04/2013 | CN101862325B Medicine compound containing candesartan cilexetil |
| 12/04/2013 | CN101848910B 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 12/04/2013 | CN101827811B Histone deacetylase inhibitor, preparation and use thereof |
| 12/04/2013 | CN101775005B Cadrofloxacin hydrochloride-I crystal and preparation method thereof |
| 12/04/2013 | CN101775003B Benzothiophene derivative, preparation method and application thereof |
| 12/04/2013 | CN101687043B Coated oral nicotine formulation buffered with amino acid |
| 12/04/2013 | CN101646664B Furanone compounds |
| 12/04/2013 | CN101636150B Method for producing pulverized organic compound particle |
| 12/04/2013 | CN101622243B Sulfonamide derivative |
| 12/04/2013 | CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 12/04/2013 | CN101613264B Annulenone compounds and application thereof in preparing anti-tumor medicaments |
| 12/04/2013 | CN101550127B Two crystal substances of bicycle-ethanol, preparation method, pharmaceutical composition and application thereof |
| 12/04/2013 | CN101505776B Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 12/04/2013 | CN101472585B Antibacterial compositions |
| 12/04/2013 | CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/04/2013 | CN101460476B Organic compounds |
| 12/04/2013 | CN101460222B Thioninium compounds and their use |
| 12/04/2013 | CN101454004B Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 12/04/2013 | CN101443340B Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |
| 12/04/2013 | CN101351203B Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 12/04/2013 | CN101331132B [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders |
| 12/04/2013 | CN101137673B Cripto结合分子 Cripto binding molecules |
| 12/03/2013 | US8598370 Process for producing threo-3-(3,4-dihydroxyphenyl)-L-serine |
| 12/03/2013 | US8598360 Apoptosis signal-regulating kinase inhibitors |
| 12/03/2013 | US8598359 Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation |
| 12/03/2013 | US8598357 Benzodioxole piperidine compounds |
| 12/03/2013 | US8598356 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 12/03/2013 | US8598354 Compounds having antiparasitic or anti-infectious activity |
| 12/03/2013 | US8598353 Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors |
| 12/03/2013 | US8598346 Synthesis of cyclic amidines |
| 12/03/2013 | US8598344 CDKI pathway inhibitors and uses thereof |
| 12/03/2013 | US8598342 Methods and compounds for antimicrobial intervention |
| 12/03/2013 | US8598235 Treating impulse control disorders with catechol-O-methyl-transferase inhibitors |
| 12/03/2013 | US8598233 Method for administering an NMDA receptor antagonist to a subject |
| 12/03/2013 | US8598232 Process for the preparation of non-genotoxic diacetylrhein (diacerein) and formulations comprising non-genotoxic diacetylrhein |
| 12/03/2013 | US8598231 Flavoring agents containing bio-derived 1,3-propanediol and its conjugate esters |
| 12/03/2013 | US8598230 Methods for inhibiting tumor cell proliferation |
| 12/03/2013 | US8598229 Tiglien-3-one derivatives |
| 12/03/2013 | US8598228 Cinnamic acid ascorbates |
| 12/03/2013 | US8598227 Epoprostenol formulation and method of making thereof |
| 12/03/2013 | US8598226 Fused cyclic compounds |
| 12/03/2013 | US8598225 Use of L-butylphthalide in the manufacture of medicaments for treatment of cerebral infarct |
| 12/03/2013 | US8598224 Method for treating cannabinoid receptor related diseases with cannabinoid receptor ligands |
| 12/03/2013 | US8598223 Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid |
| 12/03/2013 | US8598222 Method for preparing 1,3,4-substituted pyrazol compounds |
| 12/03/2013 | US8598221 Synergistic combination of analgesic compounds |
| 12/03/2013 | US8598220 Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
| 12/03/2013 | US8598218 Liquid pharmaceutical formulations of palonosetron |
| 12/03/2013 | US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases |
| 12/03/2013 | US8598216 Ritonavir bis-hydrochloride |
| 12/03/2013 | US8598215 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 12/03/2013 | US8598213 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 12/03/2013 | US8598212 Therapeutic agent and preventative agent for alzheimer's disease |
| 12/03/2013 | US8598211 Carboxamide compounds and their use as calpain inhibitors IV |
| 12/03/2013 | US8598210 Prolyl hydroxylase inhibitors and methods of use |
| 12/03/2013 | US8598209 P2X3, receptor antagonists for treatment of pain |
| 12/03/2013 | US8598208 Pyridine derivatives as S1P1/EDG1 receptor modulators |
| 12/03/2013 | US8598207 Compositions containing opioid antagonists |
| 12/03/2013 | US8598206 Trypsin-like serine protease inhibitors, and their preparation and use |
| 12/03/2013 | US8598205 Modulators of cystic fibrosis transmembrane conductance regulator |
| 12/03/2013 | US8598204 1,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligands |
| 12/03/2013 | US8598203 Treatment of Crohn's disease with laquinimod |
| 12/03/2013 | US8598202 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 12/03/2013 | US8598201 Polymorphs of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride |